Clinical Trials in Ohio

Showing 1721-1740 of 10,042 trials

Evaluate the Safety and Effectiveness of the Polymotion Hip Resurfacing (PHR) System Compared to Total Hip Arthroplasty

NCT06792539

The goal of this clinical trial is to evaluate the safety and effectiveness of the Polymotion Hip Resurfacing (PHR) System compared to total hip arthroplasty, for adults who require hip resurfacing arthroplasty due to 1) non-inflammatory arthritis (degenerative joint disease) such as osteoarthritis, traumatic arthritis, or 2) mild dysplasia/developmental dislocation of the hip (DDH) up to Crowe Grade 1.

Osteoarthritis of the HipDegenerative Joint Disease of HipDysplasia; Hip

JointMedica Inc.238 participantsStarted Jan 2025

Tampa, Florida, United States • Chicago, Illinois, United States • Baltimore, Maryland, United States +7 more locations

Active Not Recruiting24 miles

MDR - Biomet Cannulated Screws

NCT04002518

The objective of this retrospective enrollment/prospective follow up study is to collect data confirming safety, performance, and clinical benefits of the Biomet Cannulated Bone Screw System (Implants and Instrumentation) when used according to the approved Indications for Use (IFU).

Fractures, BoneFracture Multiple

Zimmer Biomet51 participantsStarted Aug 2019

Warsaw, Indiana, United States • Worthington, Ohio, United States • Lake Ridge, Virginia, United States

Evaluate the Safety and Effectiveness of the Polymotion Hip Resurfacing (PHR) System Compared to Total Hip Arthroplasty

MDR - Biomet Cannulated Screws

Find Trials by Condition in Ohio

To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate

Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer

Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery

Using Re-inforcement Learning to Automatically Adapt a Remote Therapy Intervention (RTI) for Reducing Adolescent Violence Involvement

Study of Intratumoral (IT) Ulevostinag (MK-1454) in Combination With Intravenous (IV) Pembrolizumab (MK-3475) Compared to IV Pembrolizumab Alone as the First Line Treatment of Metastatic or Unresectable, Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) (MK-1454-002)

OCS Heart Perfusion Post-Approval Registry

Comparing Surgical and Endovascular Arteriovenous Fistula Creation

Study of Posterior Cervical Stabilization System (PCSS) as Part of Circumferential Fusion to Treat Multilevel DDD

Safety Study of Adenovirus Vector Engineered to Express hIL-12 in Combination With Activator Ligand to Treat Melanoma

Combining a Smartphone App With Medications to Manage Heavy Drinking

Access Cannulation Trial II

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema

A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With Cold Agglutinin Disease (CAD)

A Study of Pembrolizumab (MK-3475) in Relapsed or Refractory Classical Hodgkin's Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-B68)

Individualizing Treatment for Asthma in Primary Care (Full Study)

The CALERIE™ Legacy Study

Clinical Validation Study of the Eximis CS (Contained Segmentation) System

PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.